Cancer-related fatigue among patients with advanced cancer receiving immune-checkpoint inhibitors: a prospective study.

[1]  A. Schandl,et al.  Cancer-related fatigue trajectories up to 5 years after curative treatment for oesophageal cancer , 2023, British journal of cancer.

[2]  S. K. Singh,et al.  Advancements in Cancer Immunotherapies , 2022, Vaccines.

[3]  R. Dantzer,et al.  The GDF15-GFRAL axis mediates chemotherapy-induced fatigue in mice , 2022, Brain, Behavior, and Immunity.

[4]  I. Kiss,et al.  Incidence of fatigue associated with immune checkpoint inhibitors in patients with cancer: a meta-analysis , 2022, ESMO open.

[5]  A. Kulasinghe,et al.  Immune Checkpoint Inhibitors in Cancer Therapy , 2022, Current oncology.

[6]  J. Sosman,et al.  Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  Douglas B. Johnson,et al.  Immune-checkpoint inhibitors: long-term implications of toxicity , 2022, Nature Reviews Clinical Oncology.

[8]  Yibo Gao,et al.  Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis. , 2021, The Lancet. Oncology.

[9]  A. Bass,et al.  Immune Checkpoint Inhibitor Therapy Toxicities-Reply. , 2021, JAMA.

[10]  M. Irwin,et al.  Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer , 2021, Cancer.

[11]  A. Bass,et al.  Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy. , 2021, JAMA.

[12]  H. Jim,et al.  Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors , 2020, Cancers.

[13]  V. Arndt,et al.  Cancer-Related Fatigue: Causes and Current Treatment Options , 2020, Current Treatment Options in Oncology.

[14]  D. Mallardo,et al.  Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice , 2019, Journal of Translational Medicine.

[15]  Jeffrey A. Engelman,et al.  Prospects for combining targeted and conventional cancer therapy with immunotherapy , 2017, Nature Reviews Cancer.

[16]  A. Mehrabi,et al.  Treatment-associated Fatigue in Cancer Patients Treated with Immune Checkpoint Inhibitors; a Systematic Review and Meta-analysis. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[17]  J. Bower,et al.  Cancer-related fatigue—mechanisms, risk factors, and treatments , 2014, Nature Reviews Clinical Oncology.

[18]  R. Millman,et al.  Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis , 2011, Supportive Care in Cancer.

[19]  Daniel J Buysse,et al.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. , 2010, Journal of clinical epidemiology.

[20]  W. Cheung,et al.  The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. , 2009, Journal of pain and symptom management.

[21]  Kathryn A. Lee,et al.  Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy. , 2008, Journal of pain and symptom management.

[22]  Colin R. Martin,et al.  An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer , 2005, Health and quality of life outcomes.

[23]  D. Cella,et al.  Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. , 2002, Journal of pain and symptom management.

[24]  D. Cella,et al.  Fatigue in cancer patients compared with fatigue in the general United States population , 2002, Cancer.

[25]  Mark J. Smith,et al.  The Memorial Delirium Assessment Scale. , 1997, Journal of pain and symptom management.

[26]  D. Cella,et al.  Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. , 1997, Journal of pain and symptom management.

[27]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Eduardo Bruera,et al.  The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients , 1991, Journal of palliative care.

[29]  A. Zigmond,et al.  The Hospital Anxiety and Depression Scale , 1983, Acta psychiatrica Scandinavica.

[30]  P. Jacobsen,et al.  Systematic review of the Multidimensional Fatigue Symptom Inventory-Short Form , 2014, Supportive Care in Cancer.

[31]  P. Jacobsen,et al.  Further validation of the multidimensional fatigue symptom inventory-short form. , 2004, Journal of pain and symptom management.